- Home
- KRSA vs PRGS Comparison
KRSA vs PRGS Comparison
Compare KRSA & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRSA | PRGS |
|---|---|---|
| Founded | 2024 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KRSA | PRGS |
|---|---|---|
| Price | $30.08 | $44.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $44.00 | ★ $56.20 |
| AVG Volume (30 Days) | 144.5K | ★ 449.2K |
| Earning Date | 11-16-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.26 | 7.79 |
| EPS | N/A | ★ 1.58 |
| Revenue | $2,074,000.00 | ★ $397,572,000.00 |
| Revenue This Year | N/A | $7.13 |
| Revenue Next Year | N/A | $22.19 |
| P/E Ratio | ★ N/A | $28.35 |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $29.03 | $23.82 |
| 52 Week High | $37.27 | $47.25 |
Technical Indicators
Market Signals| Indicator | KRSA | PRGS |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 59.94 |
| Support Level | $29.67 | $35.97 |
| Resistance Level | $35.78 | $46.63 |
| Average True Range (ATR) | 2.32 | 1.58 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 23.33 | 71.77 |
Price Performance
Historical ComparisonAbout KRSA Korsana Biosciences Inc. Common Stock
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.
About PRGS Progress Software Corporation (DE)
Progress Software Corp provides software products that enable customers to develop, deploy, and manage AI-powered applications and digital experiences. The Company operates across North America, Latin America, Europe, the Middle East and Africa (EMEA), and Asia Pacific through subsidiaries and distributors, generating a majority of its revenue from the United States. Its product portfolio includes Progress Agentic RAG, Automate MFT, Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, and WhatsUp Gold, offering solutions for application development, data connectivity, DevOps automation, managed file transfer, network security, and digital experience. It generates maximum revenue from the United States.